By limiting iron availability, LF also affects tumor metabolism—it reduces ferritin and transferrin receptor 1 (TfR1) expression, which limits iron uptake by cancer cells, while increasing ferroportin levels, facilitating the removal of iron from cells. Here, TFRC is linked to neoplasm.